Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Systemic Sclerosis
NCT00442611Phase 2Completed
- Sponsor
- Stanford University
- Start
- Nov 2008
- Primary completion
- Jun 2011
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in systemic sclerosis (SSc) comparing Abatacept with Placebo (2 arms). Primary endpoint: Modified Rodnan Skin Score at 6 months. Started Nov 2008; status: completed.
02
Drugs
abatacept
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT00442611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442611.